Nanocarriers-Based Antimicrobial Drug Delivery
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 24770
Special Issue Editor
Interests: delivery of small molecules; gene/nucleic acid delivery; development of various nano and complex delivery systems like lipid nanoparticles; polymer nanocarriers; liposomes; microparticles; lipoplexes; extracellular vesicles; transdermal delivery; stimuli-sensitive gels
Special Issue Information
Dear Colleagues,
Combating microbial infections is challenging due to the rapid development of multi-drug resistance. Microbial diseases can be contagious or infectious, resulting in short or chronic and long-lasting illnesses. Intracellular pathogens causing brucellosis, salmonellosis, tuberculosis, etc., attack the first-line mammalian defense (macrophages and non-professional phagocytes) and continue to thrive intracellularly. On the other hand, pathogens causing pneumonia, osteomyelitis and scarlet fever avoid and escape the defense line using virulent mechanisms and thrive through extracellular reproduction. Nanocarriers—polymer/lipid-based, liposomes, micelles, metal-based, silica, fullerenes, dendrimers, zeolites, quantum dots, hydrogels and composites—have been explored for antipathogenic, microbicidal, or microbiostatic properties in various microbial infections, including those arising from biofilms. Nevertheless, nanocarriers for intracellular or extracellular infections need to be designed appropriately to target specific microbes, alleviate the resistance of the drug–pathogen interaction and toxicity and disrupt biofilms as well as increase the scope in theranostics and cosmeceuticals.
In this Special Issue, manuscripts, both original research and reviews, concerning nanocarrier-based approaches for antimicrobial drug delivery-related areas of interest in human and veterinary medicine and in the food and agriculture industry are welcome.
The topics will include, but are not limited to, the following.
Medicine/pharmaceutical/drug delivery:
- Nanocarriers (polymer/lipid-based, metallic and inorganic) for local treatment or selective targeting (active/passive) strategy of microbial infections.
- Functionalized nanocarriers or stimuli-responsive nanocarriers for microbial therapy.
- Combinatorial approach for the co-delivery of antimicrobial drugs.
- Overcoming drug resistance.
- Tackling biofilm-related infections.
- Nanoscale antimicrobial coating on biomedical and medical devices.
- Overcoming the solubility or stability issues and drug-induced side effects.
- Evaluation of antimicrobial nanocarriers in vitro (characterization), preclinical and clinical models (dermal/transdermal/pulmonary/oral/other sites)—antibacterial activity studies and cytotoxicity studies.
- Nano-antimicrobial in tropical infections—dengue, malaria, tuberculosis, zika, etc.
Food and Agriculture:
- Active packaging of antimicrobial nanocarriers for quality and safety and applications.
- Smart nano-antimicrobial food packaging.
- Nanopesticides and nanoherbicides.
- Environmental impact of nanocarriers used in food and agriculture.
Cosmetics/cosmeceuticals:
- Antimicrobial nanocarriers in cosmetics.
- Antimicrobial hair care/ skincare.
Theranostics:
- Detection of antimicrobial-resistant bacterial infections using different approaches such as photo/sensitizers and multimodal imaging approaches, among others.
Dr. Anisha D'Souza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial nanocarriers
- antimicrobial food packaging
- antibiofilm
- smart delivery of antimicrobials
- detection of multi-drug resistance pathogens
- antimicrobial resistance
- metallic nanoparticles
- stimuli-responsive nanocarriers
- combinatorial antimicrobial delivery
- nanopesticides
- nanoherbicides
- antimicrobials in hair care
- cytotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.